| License: Creative Commons Attribution 4.0 (1MB) |
- URN to cite this document:
- urn:nbn:de:bvb:355-epub-373196
- DOI to cite this document:
- 10.5283/epub.37319
Abstract
Treatment of glioblastoma (GBM) consists of microsurgical resection followed by concomitant radiochemotherapy and adjuvant chemotherapy. The best outcome regarding progression free (PFS) and overall survival (OS) is achieved by maximal resection. The foundation of a specialized neuro-oncology care center (NOC) has enabled the implementation of a large technical portfolio including functional ...

Owner only: item control page